Switch to:
CareFusion Corp (NYSE:CFN)
Research and Development
$192 Mil (TTM As of Mar. 2014)

This is the expense the company spent on research and development. CareFusion Corp's research and development for the three months ended in Mar. 2014 was $47 Mil. Its research and development for the trailing twelve months (TTM) ended in Mar. 2014 was $192 Mil.


Definition

This is the expense the company spent on research and development.

CareFusion Corp Research & Development for the trailing twelve months (TTM) ended in Mar. 2014 was 50 (Jun. 2013 ) + 48 (Sep. 2013 ) + 47 (Dec. 2013 ) + 47 (Mar. 2014 ) = $192 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms

Gross Profit


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

CareFusion Corp Annual Data

Jun07Jun08Jun09Jun10Jun11Jun12Jun13
Research & Development 000103162160148146164192

CareFusion Corp Quarterly Data

Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14
Research & Development 36454647484750484747
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide